Sec Form 13G Filing - LeMaitre George W filing for LEMAITRE VASCULAR INC (LMAT) - 2021-02-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 


SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO §240.13d-2

(Amendment No. 14)*

 

 


LeMaitre Vascular, Inc.

(Name of Issuer)

 

 


Common Stock, $0.01 Par Value

(Title of Class of Securities)

 

 

525558201

(CUSIP Number)

 

 

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

 


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

 

☐ Rule 13d-1(c)

 

☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect

to the subject class of securities, and for any subsequent amendment containing information which would alter

the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

  1 

 

NAME OF REPORTING PERSON

 

George W. LeMaitre

  2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ☐        (b)  ☐ Not applicable

 

  3

 

SEC USE ONLY

 

  4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

  

SOLE VOTING POWER

 

    2,839,436 shares * 

6

  

SHARED VOTING POWER

 

    50,000 shares **

7

  

SOLE DISPOSITIVE POWER

 

    2,839,436 shares *

8

  

SHARED DISPOSITIVE POWER

 

    50,000 shares **

  9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    2,889,436 shares

 

 *      Includes 18,445 restricted stock units subject to annual vesting conditions.

 

 **    The LeMaitre Family LLC holds 50,000 shares of common stock and is 100% owned by Christopher Lynch, as trustee for various trusts formed for the benefit of the children of George D. LeMaitre, M.D. and Cornelia W. LeMaitre, including George W. LeMaitre. The trust for the benefit of George W. LeMaitre holds a 20% membership interest in LeMaitre Family LLC. George W. LeMaitre and Christopher Lynch are the managers of LeMaitre Family LLC, with sole voting and investment power with respect to all shares held by such entity, acting by unanimous agreement.

  

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    ☐

 

    Not Applicable

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    14.1%

12

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

    IN

  

Page 2 of 5

 

Schedule 13G

 

Item 1

(a).

Name of Issuer:

     

 

 

LeMaitre Vascular, Inc. (the “Company”)

 

 

 

Item 1

(b).

Address of Issuer’s Principal Executive Offices:

     

 

 

63 Second Avenue

Burlington, MA 01803

 

 

 

Item 2

(a).

Names of Persons Filing:

     

 

 

George W. LeMaitre

 

 

 

Item 2

(b).

Address of Principal Business Office or, if None, Residence:

     

 

 

63 Second Avenue

Burlington, MA 01803

 

 

 

Item 2

(c).

Citizenship:

     

 

 

George W. LeMaitre is a citizen of the United States.

 

 

 

Item 2

(d).

Title of Class of Securities:

     

 

 

This Schedule 13G report relates to the Common Stock, par value $0.01 per share (the “Common Stock”), of LeMaitre Vascular, Inc.

 

 

 

Item 2

(e).

CUSIP Number:

     

 

 

525558201

 

Page 3 of 5

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

 

 

Not applicable.

 

 

 

Item 4.

Ownership.

 

     

 

(a)

Amount Beneficially Owned:

     

 

 

See Item 9 on page 2.

 

 

 

 

(b)

Percent of Class:

     

 

 

See Item 11 on page 2.

     

 

 

The ownership percentage above is based on an aggregate of 20,506,757 shares of common stock outstanding as of December 31, 2020, according to the Issuer. 

     

 

(c)

Number of shares as to which the person has:

 

 

See Items 5 through 8 on page 2.

     

Item 5.

Ownership of Five Percent or Less of a Class.

   

 

Not Applicable.

 

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

   

 

Not Applicable.

 

 

Item 7.

Identification and Classification of the Subsidiary which Acquired the Security  Being Reported on By the Parent Holding Company or Control Person.

   

 

Not Applicable.

 

 

Item 8.

Identification and Classification of Members of the Group.

   

 

Not Applicable.

 

 

Item 9.

Notice of Dissolution of Group.

   

 

Not Applicable.

 

 

Item 10.

Certification.

   

 

Not Applicable.

 

Page 4 of 5

 

SIGNATURES

 

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

 

Dated: February 12, 2021

 

 

 /s/ George W. LeMaitre

 

 

George W. LeMaitre

 

 

 

Page 5 of 5